Filing Details
- Accession Number:
- 0000899243-22-036194
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-17 16:33:36
- Reporting Period:
- 2022-11-15
- Accepted Time:
- 2022-11-17 16:33:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1496687 | Alec Machiels | C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue. Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-15 | 1,250 | $2.67 | 265,024 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-15 | 1,250 | $48.01 | 263,774 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-11-15 | 1,250 | $0.00 | 1,250 | $2.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
114,779 | 2023-12-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 250,000 | Indirect | Indirect Owner (Bauhaus 1 LLC) |
Common Stock | 11,950 | Indirect | Indirect Owner (Owned by Spouse) |
Common Stock | 150,000 | Indirect | Indirect Owner (Spouse Trust) |
Footnotes
- The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021.
- These securities are owned by the reporting person's spouse.
- This option was granted on December 5, 2013 and is fully vested.